Abstract No. 111 Updated Prospective Cohort Study Comparing PROVAM and OVAMA Questionnaires in Assessing Health-Related Quality of Life in Vascular Malformation Patients
Assessing health-related quality of life (HRQoL) in patients with vascular malformations (VMs) is vital due to the condition’s complexity and varied presentations, requiring long-term, multidisciplinary care. This updated analysis expands on our previous study comparing two validated HRQoL tools—PROVAM and OVAMA. While both are valid and reliable, determining the most effective for patient care remains a challenge. This study further examines patient preferences, subgroup differences, and the correlation between these PROMs and HRQoL limitations in VM patients.
vigna
0
0
Assessing health-related quality of life (HRQoL) in patients with vascular malformations (VMs) is vital due to the condition’s complexity and varied presentations, requiring long-term, multidisciplinary care. This updated analysis expands on our previous study comparing two validated HRQoL tools—PROVAM and OVAMA. While both are valid and reliable, determining the most effective for patient care remains a challenge. This study further examines patient preferences, subgroup differences, and the correlation between these PROMs and HRQoL limitations in VM patients.
